Abbott India Limited

NSE ABBOTINDIA.NS

Abbott India Limited Capital Expenditure for the year ending March 31, 2024: USD -5.79 M

Abbott India Limited Capital Expenditure is USD -5.79 M for the year ending March 31, 2024, a -39.62% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Abbott India Limited Capital Expenditure for the year ending March 31, 2023 was USD -4.15 M, a 28.50% change year over year.
Abbott India Limited Capital Expenditure for the year ending March 31, 2022 was USD -5.80 M, a -82.32% change year over year.
Abbott India Limited Capital Expenditure for the year ending March 31, 2021 was USD -3.18 M, a -52.50% change year over year.
Abbott India Limited Capital Expenditure for the year ending March 31, 2020 was USD -2.09 M, a -16.15% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

NSE: ABBOTINDIA.NS

Abbott India Limited

CEO	Mr. Sridhar Kadangode
IPO Date	Aug. 12, 2002
Location	India
Headquarters	Godrej BKC
Employees	3,814
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, pre-term labor, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Key trends

Past 5 years